相关实验视频

Updated: Sep 13, 2025

Surgical Approach and Complications of Stand-alone Lateral Trans-Psoas Interbody Fusion

Surgical Approach and Complications of Stand-alone Lateral Trans-Psoas Interbody Fusion

Published on: February 14, 2025

胰岛素依赖预测腰椎手术后的不良结果

Haseeb E Goheer¹, Alden H Newcomb², Zachary M Johnson¹

¹Department of Orthopaedic Surgery, Virginia Tech Carilion School of Medicine, Roanoke, Virginia, USA.

Journal of craniovertebral junction & spine

|August 4, 2025

概括

胰岛素依赖性糖尿病 (IDDM) 在腰椎手术患者中增加了手术和医疗并发症的风险. 胰岛素依赖性糖尿病和胰岛素独立性糖尿病都是并发症的风险因素,需要改进手术前管理.

科学领域:

脊柱外科手术脊柱外科手术
内分泌学在内分泌学.
公共卫生公共卫生

背景情况:

腰椎手术的增加率与糖尿病 (DM) 的增加相吻合.
有限的研究专门针对胰岛素依赖性作为这一手术患者群体的风险因素.
了解DM的影响对于患者的治疗结果至关重要.

研究的目的:

研究胰岛素依赖在腰椎外科手术中对术后结果的明显影响.
为了比较胰岛素依赖的DM,胰岛素独立的DM和非DM患者之间的结果.
识别与不同糖尿病状态相关的特定风险.

主要方法:

美国外科医生学院国家外科质量改进计划数据库 (2011-2022) 的回顾性分析.
将患者分为胰岛素依赖的DM (IDDM),胰岛素独立的DM (NIDDM) 和非DM组.
统计分析包括ANOVA,奇平方测试和多变量逻辑回归.

主要成果:

分析了349520名患者的队列:20159名IDDM,43,402名NIDDM,285,959名非DM患者.
IDDM是手术并发症的独立风险因素 (OR: 1.134).
IDDM还独立地增加了医疗并发症的风险 (OR: 1.256).

结论:

患有IDDM的患者在腰椎手术后面临手术并发症和医学并发症的风险增加.
无论是NIDDM还是IDDM都是术后并发症的重要独立风险因素.
这些发现支持糖尿病患者,特别是IDDM患者的手术前风险分层和管理.

关键词:

复杂性复杂性复杂性在糖尿病中,糖尿病是血糖性糖尿病.腰部脊柱腰部脊柱腰部脊柱结果就是结果.脊柱脊柱脊柱脊柱脊柱

更多相关视频

Three-dimensional Navigation-guided, Prone, Single-position, Lateral Lumbar Interbody Fusion Technique

Three-dimensional Navigation-guided, Prone, Single-position, Lateral Lumbar Interbody Fusion Technique

Published on: July 15, 2021

Novel Mini-open Transforaminal Lumbar Interbody Fusion

Novel Mini-open Transforaminal Lumbar Interbody Fusion

Published on: June 6, 2025

相关概念视频

Insulin: Dosing Regimen and Adverse Effects

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Hypoglycemia and Glucagon

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...